The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Kindred Healthcare Inc

NYSE: KND
Last

(U.S.) $18.44

Today's change+0.10 +0.55%
Updated December 18 2:34 PM EST. Delayed by at least 15 minutes.
 

Kindred Healthcare Inc

NYSE: KND
Last

(U.S.) $18.44

Today's change+0.10 +0.55%
Updated December 18 2:34 PM EST. Delayed by at least 15 minutes.

Kindred Healthcare Inc up (U.S.)$0.10

Kindred Healthcare Inc is up today by (U.S.)$0.10 or 0.55% to (U.S.)$18.44. Over the last five days, shares have gained 2.05%, but sit 4.86% above the 52-week low. Shares have underperformed the S&P 500 by 16.76% during the last year.

Key company metrics

  • Open(U.S.) $18.56
  • Previous close(U.S.) $18.34
  • High(U.S.) $18.85
  • Low(U.S.) $18.40
  • Bid / Ask(U.S.) $18.44 / (U.S.) $18.45
  • YTD % change-6.59%
  • Volume388,908
  • Average volume (10-day)1,536,624
  • Average volume (1-month)2,021,574
  • Average volume (3-month)1,295,550
  • 52-week range(U.S.) $17.59 to (U.S.) $26.81
  • Beta2.20
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.81×
  • Forward PEG1.40×
  • Indicated annual dividend(U.S.) $0.48
  • Dividend yield2.60%
  • Trailing EPS(U.S.) -$1.04
Updated December 18 2:34 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-0.78%

Kindred Healthcare Inc has a net profit margin of -0.78%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.42%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,2431,2761,2871,195
Total other revenue--------
Total revenue1,2431,2761,2871,195
Gross profit1,1641,1951,2051,118
Total cost of revenue79818277
Total operating expense1,2121,2321,2261,235
Selling / general / administrative837851855804
Research & development--------
Depreciation / amortization39393937
Interest expense (income), net operating--------
Unusual expense (income)00076
Other operating expenses, total257261250240
Operating income314461-40
Interest income (expense), net non-operating-23-81-26-25
Gain (loss) on sale of assets--------
Other--------
Income before tax9-3436-64
Income after tax6-2122-46
Income tax, total3-1314-17
Net income-4-368-66
Total adjustments to net income0000
Net income before extra. items2-2617-48
Minority interest-4-5-5-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2-2617-48
Inc. avail. to common incl. extra. items-4-368-66
Diluted net income-4-368-66
Dilution adjustment00--0
Diluted weighted average shares63545352
Diluted EPS excluding extraordinary itemsvalue per share0.03-0.480.33-0.93
Dividends per sharevalue per share0.120.120.120.12
Diluted normalized EPSvalue per share0.03-0.480.330.02